Terms: = Prostate cancer AND NCOA2, TIF2, 10499, ENSG00000140396, NCoA-2, MGC138808 AND Prognosis
4 results:
1. Qingdai Decoction suppresses prostate cancer growth in lethal-stage prostate cancer models.
Chen Y; Zhou Q; Zhang H; Xu L; Lu L; Shu B; Zhou L; Yuan F
J Ethnopharmacol; 2023 May; 308():116333. PubMed ID: 36863640
[TBL] [Abstract] [Full Text] [Related]
2. Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive prostate cancer.
Malihi PD; Graf RP; Rodriguez A; Ramesh N; Lee J; Sutton R; Jiles R; Ruiz Velasco C; Sei E; Kolatkar A; Logothetis C; Navin NE; Corn P; Aparicio AM; Dittamore R; Hicks J; Kuhn P; Zurita AJ
Clin Cancer Res; 2020 Aug; 26(15):4143-4153. PubMed ID: 32341031
[TBL] [Abstract] [Full Text] [Related]
3. ncoa2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer.
Silva MP; Barros-Silva JD; Vieira J; Lisboa S; Torres L; Correia C; Vieira-Coimbra M; Martins AT; Jerónimo C; Henrique R; Paulo P; Teixeira MR
Genes Chromosomes Cancer; 2016 Apr; 55(4):365-74. PubMed ID: 26799514
[TBL] [Abstract] [Full Text] [Related]
4. prostate cancer genomic signature offers prognostic value.
Troutman SM; Price DK; Figg WD
Cancer Biol Ther; 2010 Dec; 10(11):1079-80. PubMed ID: 21088497
[TBL] [Abstract] [Full Text] [Related]
